Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 16/20 | 0.62 |
| ▸ | MTNR1B | P49286 | 15/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7894811 | 0.87 | MTNR1A (0.71) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7894801 | 0.86 | MTNR1A (0.65) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL13436452 | 0.85 | MTNR1A (0.76) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7888494 | 0.82 | MTNR1A (0.54) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7891028 | 0.82 | MTNR1A (0.58) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL13436443 | 0.79 | MTNR1A (0.86) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL4393644 | 0.77 | MTNR1A (1.00) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7894816 | 0.76 | MTNR1A (0.80) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL13436432 | 0.76 | MTNR1A (0.79) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL13436453 | 0.75 | MTNR1A (0.79) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6180657-B1 | SLEEP DISORDERS | ELI LILLY AND COMPANY | 2001-01-30 | — | — | US | disclosed |
| US-5770610-A | ADMINISTERING R-(+)-N-(2-METHYL-2-(5-METHOXY-6-CHLOROINDOL-3-YL)ETHYL) ACETAMIDE | ELI LILLY AND COMPANY (US) | 1998-06-23 | — | — | US | disclosed |
| US-5654325-A | Melatonin derivatives for use in treating sleep disorders | ELI LILLY AND COMPANY (US) | 1997-08-05 | — | — | US | disclosed |
| WO-1997000069-A1 | MELATONIN AGONISTS FOR TREATING BENIGN PROSTATIC HYPERPLASIA | ELI LILLY AND COMPANY (US) | 1997-01-03 | — | — | WO | disclosed |
| EP-0748627-A2 | Melatonin agonists for use in the treatment of benign prostatic hyperplasia | ELI LILLY AND COMPANY (US) | 1996-12-18 | — | — | EP | disclosed |
| EP-0656209-A2 | Melatonin derivatives for use in treating desynchronization disorders | ELI LILLY AND COMPANY (US) | 1995-06-07 | — | — | EP | disclosed |
| EP-0655243-A2 | Melatonin derivatives for use in treating sleep disorders | ELI LILLY AND COMPANY (US) | 1995-05-31 | — | — | EP | disclosed |
| US-4087444-A | Amides as ovulation inhibitors | ELI LILLY AND COMPANY (US) | 1978-05-02 | — | — | US | disclosed |